Cardiologists detail world’s first implant of new device for ‘no-option’ chest pain patients

Interventional cardiologists in Canada have performed the world’s first implant of a new coronary sinus reducer designed to treat chest pain patients who see no benefits from other available interventional or surgical treatments. The A-Flux Reducer System was designed and developed by VahatiCor, a new medical device company associated with California-based T45 Labs.

Post-implant angiography results confirming a successful implant of the A-Flux Reducer System in a patient's coronary sinus to reduce angina. Image courtesy of EuroIntervention and Paradis et al.

The A-Flux Reducer System by VahatiCor was designed to “conform seamlessly” to any patient’s anatomy, and it can be repositioned or retrieved as necessary.